Stock listing
NASDAQ:ITOS Iteos Therapeutics Inc Stock
Follow Iteos Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ITOS
$10.15 USD
Close on Aug 29, 2025 · No longer trades
- Lowest – highest close
- $5.04 – $47.86 USDSince Jul 24, 2020 · lowest Apr 8, 2025 · highest Dec 28, 2021
Delisted NASDAQ:ITOS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ITOS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Iteos Therapeutics Inc on 6ix
- Calls
- 3 calls with a replay · 3 with a transcript · latest Nov 10, 2021
- Decks
- 8 decks · latest Jan 13, 2025
Events
| Call | When | Status |
|---|---|---|
| Iteos Therapeutics (ITOS) Q3 2021 Earnings Call | Wed, Nov 10, 2021 · 4:30 PM ET | Replay |
| Iteos Therapeutics (ITOS) Q2 2021 Earnings Call | Thu, Aug 12, 2021 · 8:00 AM ET | Replay |
| Iteos Therapeutics (ITOS) Q1 2021 Earnings Call | Thu, May 13, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| JPM HC Conference January 2025 | Conference | 29 slides | Jan 13, 2025 |
| ESMO 2024 | Conference | 20 slides | Sep 16, 2024 |
| Investor Presentation (January 2024) | Investor deck | 27 slides | Jan 10, 2024 |
| Investor Presentation (January 2023) | Investor deck | 18 slides | Jan 9, 2023 |
| Investor Presentation (January 2022) | Investor deck | 12 slides | Jan 11, 2022 |
| Corporate Update (April 2021) | Corporate update | 19 slides | Apr 12, 2021 |
| Investor Presentation (January 2021) | Investor deck | 16 slides | Jan 11, 2021 |
| Investor Presentation (November 2020) | Investor deck | 27 slides | Nov 12, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Jun 9, 2022 – Jun 9, 2022 · Past |
| David L. Hallal Other companies: Scholar Rock Holding Corporation (Chairman and Chief Executive Officer · Since at least Jun 27, 2024); Kalaris Therapeutics, Inc. (Director · Since at least Jun 6, 2024); Seer, Inc. (Director · Jun 12, 2024 – Jun 12, 2024 · Past) | Director · Since at least Jun 11, 2024 |
| Aaron I Davis Other companies: Tango Therapeutics, Inc. (Director · Jun 8, 2022 – Aug 11, 2023 · Past); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past) | Director · Jul 23, 2020 – Jun 11, 2024 · Past |
| Matthew Gall Other companies: Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Apr 15, 2026); Kalaris Therapeutics, Inc. (Chief Financial Officer · Since at least Nov 3, 2025) | Chief Financial Officer · Since at least Jul 23, 2020 |
| Matthew Roden Other companies: Aktis Oncology, Inc. (President, Chief Executive Officer · Since at least Jan 8, 2026); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past) | Director · Nov 9, 2020 – Jun 9, 2022 · Past |
| Michel Detheux Other companies: Vor Biopharma Inc. (Member of the Audit Committee · Since at least Jul 16, 2025) | Chief Executive Officer, Director · Since at least Jul 23, 2020 |
| David Feltquate | Chief Medical Officer · Since at least Jul 31, 2024 |
| David K Lee | Director · Since at least Dec 5, 2023 |
| Joanne Jenkins Lager | Chief Medical Officer · Jul 23, 2020 – Mar 9, 2023 · Past |
| Yvonne McGrath | Chief Scientific Officer · Since at least Mar 1, 2021 |
Log in to ask 6ix AI your own questions about Iteos Therapeutics Inc.